Article

Applied Clinical Trials

Clinerion and the P-HIS Development Group of Korea University Medical Center Collaborate

Clinerion has signed a Memorandum of Understanding with the P-HIS Development Group of Korea University Medical Center to support activities in developing a patient data platform in the Republic of Korea for precision medicine.

Read the full release here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
Eli Lilly’s Investigational Oral GLP-1 Receptor Agonist Demonstrates Significant Weight Loss
August 8th 2025

Eli Lilly’s Investigational Oral GLP-1 Receptor Agonist Demonstrates Significant Weight Loss

Don Tracy, Associate Editor
ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials
August 8th 2025

ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials

Applied Clinical Trials Editorial Staff
Credit: Lars Neumann | stock.adobe.com
August 8th 2025

FDA Supports Continued Development of Eftilagimod Alfa in PD-L1–Negative Head and Neck Cancer

Andy Studna, Senior Editor
Unifying Industry to Better Understand GCP Guidance
August 8th 2025

Unifying Industry to Better Understand GCP Guidance

Andy Studna, Senior Editor
MetaVia Expands GLP-1 Glucagon Receptor Agonist Obesity Trial Amid Signs of Superior Tolerability
August 8th 2025

MetaVia Expands GLP-1 Glucagon Receptor Agonist Obesity Trial Amid Signs of Superior Tolerability

Don Tracy, Associate Editor
Navigating Complexity: Strategies to Accelerate Modern Clinical Trials
August 8th 2025

Navigating Complexity: Strategies to Accelerate Modern Clinical Trials

Cindy Henderson
© 2025 MJH Life Sciences

All rights reserved.